Epidemiology

Sarcoidosis

Volumn , Issue , 2012, Pages 15-23

  Cullinan, Paul ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84983579054     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (82)

1. Abe C, Iwai K, Mikami R, Hosoda Y (1984). Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes. Zentralbl Bakteriol Mikrobiol Hyg A 256: 541-7.
2. Almenoff PL, Johnson A, Lesser M, Mattman LH (1996). Growth of acid-fast L forms from the blood of patients with sarcoidosis. Thorax 51: 530-3.
3. Anderson R, Brett GZ, James DG, Siltzbach LE (1963). The prevalence of intrathoracic sarcoidosis. Med Thorac 20: 152-62.
4. Arima K, Ando M, Ito K et al. (1992). Effect of cigarette smoking on prevalence of summer-type hypersensitivity pneumonitis caused by Trichosporon cutaneum. Arch Environ Health 47: 274-8.
5. Bardinas F, Morera J, Fite E, Plasencia A (1989). Seasonal clustering of sarcoidosis. Lancet 2(8660): 455-6.
6. Bauer HJ, Löfgren S (1964). International study of pulmonary sarcoidosis in mass chest radiography. Acta Med Scand Suppl 425: 103-5.
7. Baughman RP, Teirstein AS, Judson MA et al. (2001). Clinical characteristics of patients in a case-control study of sarcoidosis. Am J Respir Crit Care Med 164(10 Pt 1): 1885-9.
8. Benatar SR (1997). Sarcoidosis in South Africa: a comparative study in Whites, Blacks and Coloureds. S Afr Med J 52: 602-6.
9. Boros DL (1986a). Immunoregulation of granuloma formation in murine schistosomiasis mansoni. Ann NY Acad Sci 465: 313-23.
10. Boros DL (1986b). Experimental granulomatosis. Clin Dermatol 4(4): 10-21.
11. Brennan NJ, Crean P, Long JP, Fitzgerald MX (1984). High prevalence of familial sarcoidosis in an Irish population. Thorax 39: 14-18.
12. Bresnitz EA, Strom BL (1983). Epidemiology of sarcoidosis. Epidemiol Rev 5: 124-56.
13. Bresnitz EA, Stolley PD, Israel HL, Soper K (1986). Possible risk factors for sarcoidosis: a case-control study. Ann NY Acad Sci 465: 632-42.
14. Brown ST, Brett I, Almenoff PL et al. (2003). Recovery of cell walldeficient organisms from blood does not distinguish between patients with sarcoidosis and control subjects. Chest 123: 413-17.
15. BTTA (1969). Geographical variations in the incidence of sarcoidosis in Great Britain: a comparative study of four areas. A report to the Research Committee of the British Thoracic and Tuberculosis Association. Tubercle 50: 211-32.
16. Buck AA, Sartwell PE (1961). Epidemiologic investigations of sarcoidosis. II: Skin sensitivity and environmental factors. Am J Hyg 74: 152-73.
17. Byg KE, Milman N, Hansen S (2003). Sarcoidosis in Denmark, 1980-1994: a registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis 20: 46-52.
18. Chapman JS, Speight M (1964). Further studies of mycobacterial antibodies in the sera of sarcoidosis patients. Acta Med Scand Suppl 425: 61-7.
19. Cosma CL, Humbert O, Ramakrishnan L (2004). Superinfecting mycobacteria home to established tuberculous granulomas. Nat Immunol 5: 828-35.
20. Cummings MM, Dunner E, Williams JH (1959). Epidemiologic and clinical observations in sarcoidosis. Ann Intern Med 50: 879-90.
21. Douglas JG, Middleton WG, Gaddie J et al. (1986). Sarcoidosis: a disorder commoner in non-smokers? Thorax 41: 787-91.
22. Ebe Y, Ikushima S, Yamaguchi T et al. (2000). Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 17: 256-65.
23. Edmondstone WM (1988). Sarcoidosis in nurses: is there an association? Thorax 43: 342-3.
24. Edmondstone WM, Wilson AG (1985). Sarcoidosis in Caucasians, Blacks and Asians in London. Br J Dis Chest 79(1): 27-36.
25. Eishi Y, Suga M, Ishige I et al. (2002). Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 40: 198-204.
26. Fog J, Wilbek E (1974). [The epidemiology of sarcoidosis in Denmark]. Ugeskr Laeger 136: 2183-91.
27. Gideon NM, Mannino DM (1996). Sarcoidosis mortality in the United States, 1979-1991: an analysis of multiple-cause mortality data. Am J Med 100: 423-7.
28. Gorham ED, Garland CF, Garland FC et al. (2004). Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel: a 27-year historical prospective study, 1975-2001. Chest 126: 1431-8.
29. Gribbin J, Hubbard RB, Le JI et al. (2006). Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 61: 980-5.
30. Gupta D, Agarwal R, Aggarwal AN, Jindal SK (2007). Molecular evidence for the role of mycobacteria in sarcoidosis: a metaanalysis. Eur Respir J 30: 508-16.
31. Harf RA, Ethevenaux C, Gleize J et al. (1986). Reduced prevalence of smokers in sarcoidosis: results of a case-control study. Ann NY Acad Sci 465: 625-31.
32. Headings VE, Weston D, Young RC, Hackney RL (1976). Familial sarcoidosis with multiple occurrences in eleven families: a possible mechanism of inheritance. Ann NY Acad Sci 278: 377-85.
33. Henke CE, Henke G, Elveback LR et al. (1986). The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol 123: 840-5.
34. Hennessy TW, Ballard DJ, DeRemee RA et al. (1988). The influence of diagnostic access bias on the epidemiology of sarcoidosis: a population-based study in Rochester, Minnesota, 1935-1984. J Clin Epidemiol 41: 565-70.
35. Hillerdal G, Nou E, Osterman K, Schmekel B (1984). Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 130: 29-32.
36. Hills SE, Parkes SA, Baker SB (1987). Epidemiology of sarcoidosis in the Isle of Man. 2: Evidence for space-time clustering. Thorax 42: 427-30.
37. Hiraga Y, Hosoda Y, Odaka M (1974). Epidemiology of sarcoidosis in a Japanese working group: a ten-year study. In: Iwai K, Hosoda Y (eds). Proceedings of the 6th International Conference on Sarcoidosis. Tokyo, Japan, pp. 303-6.
38. Hosoda Y, Hiraga Y, Odaka M et al. (1976). A cooperative study of sarcoidosis in Asia and Africa: analytic epidemiology. Ann NY Acad Sci 278: 355-67.
39. Hutchinson J (1877). Case of livid papillary psoriasis. In: Illustrations of Clinical Surgery. J&A Churchill, London, pp. 42-3.
40. Ichiyasu H, Suga M, Matsukawa A et al. (1999). Functional roles of MCP-1 in Propionibacterium acnes-induced, T cell-mediated pulmonary granulomatosis in rabbits. J Leukoc Biol 65: 482-91.
41. Ishige I, Eishi Y, Takemura T et al. (2005). Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22: 33-42.
42. Ishige I, Usui Y, Takemura T, Eishi Y (1999). Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 354(9173): 120-3.
43. Israel HL, Washburne JD (1980). Characteristics of sarcoidosis in black and white patients. In: Proceedings of the 8th International Conference on Sarcoidosis. Alpha Omega, Cardiff, pp. 497-507.
44. Izbicki G, Chavko R, Banauch GI et al. (2007). World Trade Center ‘sarcoid-like’ granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest 131: 1414-23.
45. Jawad AS, Hamour AA, Wenley WG, Scott DG (1989). An outbreak of acute sarcoidosis with arthropathy in Norfolk. Br J Rheumatol 28(2): 178.
46. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) (1999). Am J Respir Crit Care Med 160: 736-55.
47. Kajdasz DK, Lackland DT, Mohr LC, Judson MA (2001). A current assessment of rurally linked exposures as potential risk factors for sarcoidosis. Ann Epidemiol 11: 111-17.
48. Kern DG, Neill MA, Wrenn DS, Varone JC (1993). Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis 148(4 Pt 1): 974-80.
49. Kreider ME, Christie JD, Thompson B et al. (2005). Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 128: 207-15.
50. McDonough C, Gray GC (2000). Risk factors for sarcoidosis hospitalization among US Navy and Marine Corps personnel, 1981-1995. Mil Med 165: 630-2.
51. McGrath DS, Daniil Z, Foley P et al. (2000). Epidemiology of familial sarcoidosis in the UK. Thorax 55: 751-4.
52. McGregor I (1961). The Two Year Mass Radiography Campaign in Scotland, 1957-1958 [abstract]. HMSO, Edinburgh.
53. Milman N, Selroos O (1990). Pulmonary sarcoidosis in the Nordic countries, 1950-1982: epidemiology and clinical picture. Sarcoidosis 7(1): 50-7.
54. Mitchell DN, Rees RJ (1969). A transmissible agent from sarcoid tissue. Lancet 2(7611): 81-4.
55. Mitchell DN, Rees RJ (1970). An attempt to demonstrate a transmissible agent from sarcoid material. Postgrad Med J 46: 510-14.
56. Mitchell DN, Rees RJ, Goswami KK (1976). Transmissible agents from human sarcoid and Crohn’s disease tissues. Lancet 2(7989): 761-5.
57. Moller DR, Chen ES (2002). What causes sarcoidosis? Curr Opin Pulm Med 8: 429-34.
58. Morimoto Y, Kohyama S, Nakai K et al. (2003). Long-term effects of UV light on contractility of rat arteries in vivo. Photochem Photobiol 78: 372-6.
59. Narayanan RB (1988). Immunopathology of leprosy granulomas. Current status: a review. Lepr Rev 59(1): 75-82.
60. Newman LS, Rose CS, Bresnitz EA et al. (2004). A case-control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170: 1324-30.
61. Panayeas S, Theodorakopoulos P, Bouras A, Constantopoulos S (1991). Seasonal occurrence of sarcoidosis in Greece. Lancet 338(8765): 510-11.
62. Parkes SA, Baker SB, Bourdillon RE et al. (1985). Incidence of sarcoidosis in the Isle of Man. Thorax 40: 284-7.
63. Pietinalho A, Ohmichi M, Hiraga Y et al. (1996). The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan: a comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc Diffuse Lung Dis 13: 159-66.
64. Pike MC, Smith PG (1974). Case-control approach to examine diseases for evidence of contagion, including diseases with long latent periods. Biometrics 30: 263-79.
65. Prezant DJ, Dhala A, Goldstein A et al. (1999). The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest 116: 1183-93.
66. Rabin DL, Thompson B, Brown KM et al. (2004). Sarcoidosis: social predictors of severity at presentation. Eur Respir J 24: 601-8.
67. Riddervold L (1964). Sarcoidosis in Norway. Acta Med Scand Suppl 425: 111.
68. Rossman MD, Kreider ME (2007). Lesson learned from ACCESS (A Case Controlled Etiologic Study of Sarcoidosis). Proc Am Thorac Soc 4: 453-6.
69. Rybicki BA, Iannuzzi MC, Frederick MM et al. (2001). Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 164: 2085-91.
70. Rybicki BA, Major M, Popovich J et al. (1997). Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145: 234-41.
71. Sartwell PE, Edwards LB (1974). Epidemiology of sarcoidosis in the US Navy. Am J Epidemiol 99: 250-7.
72. Scharkoff T (1987). Apropos of the present level of epidemiologic knowledge on sarcoidosis. Sarcoidosis 4: 152-4.
73. Schurmann M, Lympany PA, Reichel P et al. (2000). Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med 162(3 Pt 1): 861-4.
74. Sharma OP, Neville E, Walker AN, James DG (1976). Familial sarcoidosis: a possible genetic influence. Ann NY Acad Sci 278: 386-400.
75. Song Z, Marzilli L, Greenlee BM et al. (2005). Mycobacterial catalaseperoxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 201: 755-67.
76. Stewart IC, Davidson NM (1982). Clustering of sarcoidosis. Thorax 37: 398-9.
77. Sutherland I, Mitchell DN, Hart PD (1965). Incidence of intrathoracic sarcoidosis among young adults participating in a trial of tuberculosis vaccines. Br Med J 2(5460): 497-503.
78. Terris M, Chaves AD (1966). An epidemiologic study of sarcoidosis. Am Rev Respir Dis 94(1): 50-5.
79. Wallgren S (1958). Pulmonary sarcoidosis detected by photofluorographic surveys in Sweden, 1950-1957. Nord Med 60: 1194-5.
80. Yamaguchi M, Hosoda Y, Sasaki R, Aoki K (1989). Epidemiological study on sarcoidosis in Japan: recent trends in incidence and prevalence rates and changes in epidemiological features. Sarcoidosis 6(2): 138-46.
81. Yi ES, Lee H, Suh YK et al. (1996). Experimental extrinsic allergic alveolitis and pulmonary angiitis induced by intratracheal or intravenous challenge with Corynebacterium parvum in sensitized rats. Am J Pathol 149: 1303-12.
82. Young RC, Hackney RL, Harden KA (1974). Epidemiology of sarcoidosis: ethnic and geographic considerations. J Natl Med Assoc 66: 386-8.